Active — Not RecruitingNot Applicable

Follow up of Intravesical N-803 Plus BCG in BCG-Naive Non-Muscle Invasive Bladder Cancer (NMIBC)

United States6 participantsStarted 2023-08-17

Plain-language summary

The purpose of this clinical trial is to obtain long-term follow-up information and status of bladder cancer for patients who received study treatment in the QUILT-2.005 study.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Enrolled and treated with intravesical N-803 plus BCG in the phase 1b portion of QUILT-2.005. Exclusion Criteria: * Not applicable

What they're measuring

Obtain Long Term Follow-Up data to be summarized using descriptive statistics

Timeframe: assessed up to 60 months

Assess the Complete response yearly

Timeframe: assessed up to 60 months

Asses Disease-free Survival

Timeframe: assessed up to 60 months

Trial details

NCT IDNCT05981131

SponsorImmunityBio, Inc.

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2033-08-30

View on ClinicalTrials.gov More Non Muscle Invasive Bladder Cancer trials